| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 05/22/1997 | CA2237311A1 Method for treating anxiety |
| 05/22/1997 | CA2237220A1 Method for treating anxiety |
| 05/22/1997 | CA2236594A1 Method for treating anxiety |
| 05/22/1997 | CA2235126A1 Quinoline derivatives as type iv phosphodiesterase inhibitors |
| 05/21/1997 | EP0774455A1 Excitatory amino acid receptor antagonists |
| 05/21/1997 | EP0774454A1 Excitatory amino acid receptor antagonists |
| 05/21/1997 | EP0774256A1 Use of azacyclic or azabicyclic thiadiazole compounds for treating anxiety |
| 05/21/1997 | EP0774250A1 Use of a TNF alpha antagonist against skin redness of neurogenic origin |
| 05/21/1997 | EP0774008A1 Adenovirus including a gene coding for a superoxide dismutase |
| 05/21/1997 | EP0774004A1 Dna sequences coding for the human proteins tx and ty related to the interleukin-1beta converting enzyme |
| 05/21/1997 | EP0773998A1 Novel vesicular acetylcholine carrier |
| 05/21/1997 | EP0773995A1 Dna encoding the vertebrate homolog of hedgehog, vhh-1, expressed by the notochord, and uses thereof |
| 05/21/1997 | EP0773947A1 5H-THIAZOLO 3,2-a]PYRIMIDIN-5-ONE DERIVATIVES |
| 05/21/1997 | EP0773942A1 4-indole derivatives as serotonin agonists and antagonists |
| 05/21/1997 | EP0773939A1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 05/21/1997 | EP0773937A1 Novel aryl piperazine-derived piperazide derivatives, methods for their preparation, their use as drugs and pharmaceutical compositions comprising same |
| 05/21/1997 | EP0773933A1 Optically active isomers of dihydrexidine and its substituted analogs |
| 05/21/1997 | EP0773932A1 Benzenesulfonamide derivatives used as bradykinine antagonists |
| 05/21/1997 | EP0773931A1 Quinoline derivatives as leukotriene antagonists |
| 05/21/1997 | EP0674509A4 Methods for treatment with dimercaptosuccinic acid (dmsa). |
| 05/21/1997 | EP0660718A4 Method of treating premenstrual syndrome symptomatology with vitamin d or vitamin d and calcium. |
| 05/21/1997 | EP0623138B1 New adenosine derivatives, preparation methods and pharmaceutical compositions containing them |
| 05/21/1997 | CN1150433A Diagnosis, therapy and cellular and animal models for diseases associated with mitochondrial defects |
| 05/21/1997 | CN1150428A Corticotropin releasing factor antagonists |
| 05/21/1997 | CN1150426A Novel 1,1-bis (heteroazolyl) alkane derivatives and their use as neuroprotective agents |
| 05/21/1997 | CN1150425A Cyclobut-3-ene-1,2-dione derivatives as smooth muscle relaxants |
| 05/21/1997 | CN1150390A Glial mitogenic factors, their preparation and use |
| 05/21/1997 | CN1150152A Process for manufacture of imidazo benzodiazepine derivatives |
| 05/21/1997 | CN1150151A Furan and furan amide compound and producing process and pharmaceutical composition thereof |
| 05/21/1997 | CN1034939C Process for preparing indolone and indoldione derivatives with cholinergic activity |
| 05/20/1997 | US5631402 Process for preparing aminobenzoic acid derivatives |
| 05/20/1997 | US5631373 Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones |
| 05/20/1997 | US5631296 Drugs containing S(+)-ibuprofen |
| 05/20/1997 | US5631293 Cardiovascular disorders |
| 05/20/1997 | US5631279 Antagonists of neurokinin a |
| 05/20/1997 | US5631269 Pyrazole, isooxazole or isothiazole piperidine derivatives |
| 05/20/1997 | US5631267 Method for the treatment of eosinophil-associated diseases by administration of topical anesthetics |
| 05/20/1997 | US5631265 Chemical intermediates with central nervous system activity |
| 05/20/1997 | US5631264 Substituted 6,11-ethano-6,11-dihydrobenzo[B]quinolizinium salts and compositions and methods of use thereof |
| 05/20/1997 | US5631261 Triazoloquinazolines, their preparation and use |
| 05/20/1997 | US5631257 Benzoxazole derivatives |
| 05/20/1997 | CA2073340C Centrally acting 6,7,8,9-tetrahydro-3h-benz(e)indole heterocyclics |
| 05/20/1997 | CA2064704C Onset-hastened/enhanced antipyretic response |
| 05/20/1997 | CA2044515C Cyclic amide derivatives |
| 05/18/1997 | CA2188485A1 Piperidinylethylamide derivatives as serotonergic agents |
| 05/18/1997 | CA2188484A1 Piperazinyl benzamide derivatives as serotonergic agents |
| 05/15/1997 | WO1997017460A1 Process for producing phosphatidylserines having polybasic unsaturated fatty acid as side chain |
| 05/15/1997 | WO1997017351A1 Spiro piperidine derivatives as 5mt receptor antagonists |
| 05/15/1997 | WO1997017350A1 Azaspiro derivatives with 5ht1b activity |
| 05/15/1997 | WO1997017348A1 1-azabicycloheptane derivatives and their pharmaceutical use |
| 05/15/1997 | WO1997017347A1 Compounds derived from oxazolidin-2-one and preparation and therapeutical use thereof |
| 05/15/1997 | WO1997017346A1 Compounds derived from 3-(benzofuran-5-yl)oxazolidin-2-one, preparation method therefor and therapeutical use thereof |
| 05/15/1997 | WO1997017344A1 Amidine and isothiourea derivatives as inhibitors of nitric oxide synthase |
| 05/15/1997 | WO1997017343A1 Indolealkyl derivatives of benzodioxanmethylamine as 5-ht1a receptor ligands |
| 05/15/1997 | WO1997017326A1 Enantiomers of cis-benz[e]indole compounds, their preparation and utility as dopamine-d3 receptor selective agents |
| 05/15/1997 | WO1997017317A1 4-phenyl-4-oxo-butanoic acid derivatives with kynurenine-3-hydroxylase inhibiting activity |
| 05/15/1997 | WO1997017316A1 4-phenyl-4-oxo-2-butenoic acid derivatives with kynurenine-3-hydroxylase inhibiting activity |
| 05/15/1997 | WO1997017074A1 Treatment of traumatic brain injury |
| 05/15/1997 | WO1997017068A1 Ginkgolides for inhibition of membrane expression |
| 05/15/1997 | WO1997017067A1 Sublingual and buccal administration of selegiline |
| 05/15/1997 | DE19542281A1 Verwendung von Epinastin für die Behandlung von Schmerzen Use of epinastine in the treatment of pain |
| 05/15/1997 | CA2236678A1 Indolealkyl derivatives of benzodioxanmethylamine as 5-ht1a receptor ligands |
| 05/15/1997 | CA2235416A1 Ginkgolides for inhibition of membrane expression |
| 05/15/1997 | CA2235301A1 Amidine and isothiourea derivatives as inhibitors of nitric oxide synthase |
| 05/15/1997 | CA2234824A1 Treatment of traumatic brain injury |
| 05/14/1997 | EP0773223A1 Tetracyclic 1,4-oxazine compounds, process for their preparation and pharmaceutical compositions containing them |
| 05/14/1997 | EP0773027A1 Use of azacyclic or azabicyclic pyrazine compounds for treating anxiety |
| 05/14/1997 | EP0773022A2 Pharmaceutical composition for the treatment of rhinitus, containing sympathomometic and pantothenol and/or pantothenic acid |
| 05/14/1997 | EP0773021A1 Use of azacyclic or azabicyclic oxadiazole compounds for treating anxiety |
| 05/14/1997 | EP0772619A1 Immunomodulatory oligonucleotides |
| 05/14/1997 | EP0772615A1 IMIDAZO 1,2-a]INDENO 1,2-e]PYRAZINE-2-CARBOXYLIC ACID DERIVATIVES, PREPARATION THEREOF AND DRUGS CONTAINING SAME |
| 05/14/1997 | EP0772612A1 4-hydroxy-3-phenyl-indeno(1,2-b)pyridine-2(1h)-one derivatives as nmda antagonists |
| 05/14/1997 | EP0772610A1 Dihydrobenzofuranes |
| 05/14/1997 | EP0772604A1 Triazole compounds and their use as dopamine-d 3?-ligands |
| 05/14/1997 | EP0772603A1 Substituted pyrimidine compounds and their use |
| 05/14/1997 | EP0772600A1 1,2-substituted imidazolyl compounds for the treatment of inflammation |
| 05/14/1997 | EP0772597A1 3,4-substituted pyrazoles for the treatment of inflammation |
| 05/14/1997 | EP0772585A1 Aryloxy and arylthiopropanolamine derivatives useful as beta 3-adrenoreceptor agonists and antagonists of the beta 1 and beta 2-adrenoreceptors and pharmaceutical composition thereof |
| 05/14/1997 | EP0772449A1 Pharmaceutical compositions comprising a chimaeric tnf binding protein |
| 05/14/1997 | EP0772442A1 Use of immunosuppressive agents for the treatment of schizophrenia |
| 05/14/1997 | EP0772440A1 Carbon monoxide dependent guanylyl cyclase modifiers |
| 05/14/1997 | EP0441852B1 Muscarinic receptor antagonists |
| 05/14/1997 | CN1149873A Piperazine derivatives as 5HT1A antagonists |
| 05/14/1997 | CN1149870A Substituted pyrazoles having corticotropin-releasing factor (CRF) antagonist activity |
| 05/14/1997 | CN1149869A Substituted sulfonamides as selective beta3 agonists for treatment of diabetes and obesity |
| 05/14/1997 | CN1149836A Tin-117m-containing radio therapeutic agents |
| 05/14/1997 | CN1149485A Cynanchum otophyllum for anti-Meniere's disease, usage and preparation method |
| 05/14/1997 | CN1149483A Oral liquor for curing senile dementia and constipation |
| 05/14/1997 | CN1149476A Ningshen medicinal composition for curing chronic retraction psychosis |
| 05/14/1997 | CN1149475A Ningshen medicinal composition for curing depressive psychosis |
| 05/14/1997 | CN1149474A Ningshen medicinal composition for anti-psychosis |
| 05/14/1997 | CN1149473A Ningshen medicinal composition for curing psychasthenia disease |
| 05/14/1997 | CN1149471A Nutrient for youngsters |
| 05/14/1997 | CN1034865C Preparing method for 2-aminopyrimidinone |
| 05/13/1997 | US5629347 Aromatic compounds, pharmaceutical compositions containing them and their use in therapy |
| 05/13/1997 | US5629336 Use of glycine/NMDA receptor ligands for the treatment of drug dependence and withdrawal |
| 05/13/1997 | US5629326 Analgesics and antipsychotics, indazole, benzisoxazole, and benzisothiazole derivatives |
| 05/13/1997 | US5629325 3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission |
| 05/13/1997 | US5629323 Amide derivatives as 5-HT1A ligands |
| 05/13/1997 | US5629322 Treatment of neurodegenerative disorders, disorders of gastrointestinal motility and inflammation |